HomeORGANIZATION
ORGANIZATION

Hodanren Demands Ad-Hoc Re-Pricing for Opdivo
(Sep.7.2016)

The Japanese Medical and Dental Practitioners for the Improvement of Medical Care (Hodanren) said on September 6 that it has submitted a request calling for out-of-cycle re-pricing for Ono Pharmaceutical’s immuno-oncology drug Opdivo (nivolumab) ...
(LOG IN FOR FULL STORY)

News Calendar